San Mateo, CA, United States of America

Lee B Bussey

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Juvaris Biotherapeutics, Inc., Megabios Corporation, Valentis, Inc.. Active years: 2000-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee B Bussey. Retrieved from https://idiyas.com/inventor/lee-b-bussey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 28.6


 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2000-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Lee B. Bussey

Introduction

Lee B. Bussey is a prominent inventor based in San Mateo, California, known for his significant contributions to the field of nucleic acid purification. With an impressive portfolio of seven patents, Bussey has made strides in developing innovative methods and apparatuses aimed at improving the production and purification of nucleic acids, which are crucial for various biotechnological applications, including gene therapy.

Latest Patents

Bussey's latest patents showcase his expertise in creating efficient processes for nucleic acid purification. One of his notable patents focuses on "Methods for purifying nucleic acids," which details a streamlined and automated process to produce highly purified compositions. This method employs static mixers for cell lysis and debris precipitation, complemented by centrifugation and ion exchange chromatography. Additionally, a purification step utilizing tangential flow ultrafiltration is included to yield pharmaceutical-grade plasmid DNA.

Another significant patent is for "Apparatus and method for preparative scale purification of nucleic acids." This invention describes a novel apparatus and methodology for the pharmaceutical-grade manufacture of extrachromosomal nucleic acids from cell lysates. The process uses flotation to separate undesired insoluble cellular debris, including chromosomal DNA, by introducing a gas that generates bubbles to reduce the density of the debris, resulting in a buoyant flocculent phase. This innovative approach allows for the extraction of a clarified fluid lysate phase, rich in extrachromosomal DNA and substantially free of proteins and chromosomal DNA.

Career Highlights

Throughout his career, Lee B. Bussey has worked with various organizations, including Megabios Corporation, where he has applied his expertise in bioprocessing and nucleic acid purification technologies. His work has positively impacted the field, contributing toward advancements that facilitate more effective gene therapies and biopharmaceutical production.

Collaborations

In his inventive journey, Bussey has collaborated with esteemed professionals, including Kwok-Leung (Jacky) Au-Yeung and Robert Harlan Bridenbaugh. These collaborations have fostered an environment of innovation and have helped refine his approaches to nucleic acid purification.

Conclusion

Lee B. Bussey stands out as a leading inventor in the biotechnology sector, with a focused commitment to optimizing nucleic acid purification processes. His patents reflect a deep understanding of the complexities involved in bioprocessing and an unwavering dedication to advancing the field, thereby making a significant impact on modern biotechnology and gene therapy practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…